Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation
Article in Acta Pharmacologica Sinica (May 2024)
The most recent citing publications are shown below. View all 305 publications that cite this research output on Dimensions.
Article in Acta Pharmacologica Sinica (May 2024)
Article in International Journal of Molecular Sciences (May 2024)
Article in Nature Reviews Nephrology (April 2024)